Defining the Risks for Cytomegalovirus Infection and Disease After Solid Organ Transplantation

Probabilistic Modeling of Cytomegalovirus Infection Under Consensus Clinical Management Guidelines

(2010) Svetlana Dmitrienko et al.   TRANSPLANTATION

One Step Closer to a CMV Vaccine

(2009) Cornelia L. Dekker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Delayed onset CMV disease in solid organ transplant recipients

(2009) Shahid Husain et al.   TRANSPLANT IMMUNOLOGY

Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States

(2009) Jesse D. Schold et al.   TRANSPLANT INTERNATIONAL

Alemtuzumab Induction and Steroid-Free Maintenance Immunosuppression in Pancreas Transplantation

(2008) A. S. R. Muthusamy et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Comparison of Alemtuzumab with Basiliximab Induction in Simultaneous Pancreas-Kidney Transplantation

(2008) J. F. Magliocca et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Improvement in Long-Term Renal Graft Survival due to CMV Prophylaxis with Oral Ganciclovir: Results of a Randomized Clinical Trial

(2008) V. Kliem et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Linking CMV Serostatus to Episodes of CMV Reactivation Following Lung Transplantation by Measuring CMV-Specific CD8+T-Cell Immunity

(2008) G. P. Westall et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The Combined Organ Effect

(2008) Abbas Rana et al.   ANNALS OF SURGERY

Optimal Prevention of Late‐Onset Cytomegalovirus (CMV) Disease and Other Sequelae of CMV Infection in Organ Transplant Recipients

(2008) Nina Singh   CLINICAL INFECTIOUS DISEASES

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

(2008) S. K. Arthurs et al.   CLINICAL INFECTIOUS DISEASES

Improving Outcomes for Solid-Organ Transplant Recipients At Risk from Cytomegalovirus Infection: Late-Onset Disease and Indirect Consequences

(2008) C. Legendre et al.   CLINICAL INFECTIOUS DISEASES

Impact of Current Transplantation Management on the Development of Cytomegalovirus Disease after Renal Transplantation

(2008) Rafael San Juan et al.   CLINICAL INFECTIOUS DISEASES

Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation

(2008) N.W. Cummins et al.   Transplant Infectious Disease

Clinical experience with mixed chimerism to induce transplantation tolerance

(2008) Thomas Fehr et al.   TRANSPLANT INTERNATIONAL

Experience With Alemtuzumab (Campath-1H) as Induction Agent in Renal Transplantation Followed by Steroid-Free Immunosuppression

(2008) Y. Baez et al.   TRANSPLANTATION PROCEEDINGS

Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials

(2008) L. Demopoulos et al.   TRANSPLANTATION PROCEEDINGS

Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients

(2007) David Hughes et al.   JOURNAL OF CLINICAL VIROLOGY